SCHEMBL6209701

SCHEMBL6209701

NC(=O)CC1(c2ccc(OCc3ccccc3)cc2)CCCCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.52
LTA4H P09960 1/20 0.48
NR4A1 P22736 1/20 0.48
NR4A2 P43354 1/20 0.48
NR4A3 Q92570 1/20 0.48
RORC P51449 1/20 0.47
HRH3 Q9Y5N1 1/20 0.47
MAOB P27338 2/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
PTGS1 P23219 1/20 0.45
SLC6A2 P23975 1/20 0.45
CYP2C19 P33261 1/20 0.45
PTGS2 P35354 1/20 0.45
SLC6A3 Q01959 1/20 0.45
HIF1A Q16665 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6494035 0.99 PARP10 (0.54) PARP10LTA4HNR4A1NR4A2NR4A3
SCHEMBL6505595 0.96 PARP10 (0.54) PARP10LTA4HNR4A1NR4A2NR4A3
SCHEMBL6502368 0.82 SLC6A3 (0.60) RORCMAOBRAB9ASMN1; SMN2LMNA
SCHEMBL17761202 0.82 DPP4 (0.56) MAOBSMN1; SMN2LMNASLC6A2SLC6A3
SCHEMBL6210261 0.81 DPP4 (0.62) RORCMAOBRAB9ASMN1; SMN2LMNA
SCHEMBL4866308 0.80 DPP4 (0.58) MAOBSMN1; SMN2LMNASLC6A2CYP2C19
SCHEMBL6208426 0.79 SLC6A4 (0.64) SMN1; SMN2LMNASLC6A2SLC6A3HSD11B1
SCHEMBL21874210 0.79 MEN1 (0.62) PARP10NR4A1NR4A2NR4A3RORC
SCHEMBL12836839 0.78 POLB (0.54) LMNASLC6A3HSD11B1
SCHEMBL6210983 0.78 DPP4 (0.57) PARP10LTA4HRORCMAOBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234096-A1 Tetrahydroisoquinoline derivatives BAYER HEALTHCARE AG (DE) 2005-10-20 US disclosed
EP-1507763-A1 TETRAHYDROISOQUINOLINE DERIVATIVES Bayer HealthCare AG (DE) 2005-02-23 EP disclosed
WO-2003097607-A1 TETRAHYDROISOQUINOLINE DERIVATIVES BAYER HEALTHCARE AG (DE) 2003-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234096-A1 Tetrahydroisoquinoline derivatives PPARD, PPARG, PPARA PARP10 1217/4885LTA4H 1239/4885NR4A1 103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.